BioMosaics

BioMosaics

All Products

​BioMosaics is a privately-held cancer biomarker development company located in Burlington, Vermont. The company specializes in developing and commercializing innovative products for the early diagnosis, prediction, monitoring, and treatment of cancer. ​

Product Focus:

  • Glypican-3 (GPC3) Antibodies: BioMosaics offers monoclonal antibodies targeting GPC3, an oncofetal antigen overexpressed in hepatocellular carcinoma (HCC). These antibodies are utilized for immunohistochemical detection of HCC in patient tissue samples.